This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kim, S. Articles by Kim, K. Search for Related Content PubMed PubMed Citation Articles by Kim, S. Articles by Kim, K. Social Bookmarking                         What's this?

Aluminum exposure decreases dopamine D1 and D2 receptor expression in mouse brain

Department of Safety Evaluation, Biotoxtech Company, Chungbuk 363-883, Korea, kimkisok{at}kmu.ac.kr

Jungmin Nam

Department of Public Health, Keimyung University, Taegu 704-701, Korea

Kisok Kim

Department of Public Health, Keimyung University, Taegu 704-701, Korea

Aluminum (Al) has been identified as a potential contributing factor in the etiology of several neurodegenerative disorders, but data regarding specific effects on neurotransduction, especially on dopaminergic neurotransduction, are lacking. The objective of this study was to determine the extent of expressional alterations in dopamine receptors (DRs) in two dopaminergic subtypes, D1 and D2, in low and high dose Al-treated mice. After administration of Al (four intraperitoneal injections of 30 or 60 mg/kg AlCl₃·6H₂O at 2 h intervals), expression of the dopamine D1-like and D2-like receptors (DRD1, DRD2) was examined in the cortex and striatum of mouse brain at bregma levels of 1.10, -0.10 and -1.34 mm. In the cortex, Al treatment decreased densities of DRD1 and DRD2 in a dose-dependent manner at all three bregma levels, especially in the high-dose Al group. Similarly, DRD1 and DRD2 expression in the striatum also exhibited dose dependency and statistically significant decreases were seen in the high-dose group, except in the striatum at bregma level - 1.34. These findings suggest that DR in the caudal striatum is more resistant to the effects of Al exposure than DR in the cortex or rostral striatum. In addition, our results suggest that disturbance of dopaminergic neurotransmission mediated by DRD1 and/or DRD2 may be involved in the pathogenesis of Al neurotoxicity. Human & Experimental Toxicology (2007) 26, 741 —746

Key Words: dopaminergic neurotransmission • neurodegenerative disease • neurotoxicity • rostrocaudal extent

Human & Experimental Toxicology, Vol. 26, No. 9, 741-746 (2007)
DOI: 10.1177/0960327107083973


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?